1. Home
  2. ZLAB vs DOGZ Comparison

ZLAB vs DOGZ Comparison

Compare ZLAB & DOGZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZLAB
  • DOGZ
  • Stock Information
  • Founded
  • ZLAB 2013
  • DOGZ 2003
  • Country
  • ZLAB China
  • DOGZ China
  • Employees
  • ZLAB N/A
  • DOGZ N/A
  • Industry
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • DOGZ Miscellaneous manufacturing industries
  • Sector
  • ZLAB Health Care
  • DOGZ Consumer Discretionary
  • Exchange
  • ZLAB Nasdaq
  • DOGZ Nasdaq
  • Market Cap
  • ZLAB 3.6B
  • DOGZ 399.0M
  • IPO Year
  • ZLAB 2017
  • DOGZ 2017
  • Fundamental
  • Price
  • ZLAB $32.54
  • DOGZ $9.36
  • Analyst Decision
  • ZLAB Buy
  • DOGZ
  • Analyst Count
  • ZLAB 5
  • DOGZ 0
  • Target Price
  • ZLAB $54.28
  • DOGZ N/A
  • AVG Volume (30 Days)
  • ZLAB 781.8K
  • DOGZ 450.2K
  • Earning Date
  • ZLAB 08-05-2025
  • DOGZ 03-31-2025
  • Dividend Yield
  • ZLAB N/A
  • DOGZ N/A
  • EPS Growth
  • ZLAB N/A
  • DOGZ N/A
  • EPS
  • ZLAB N/A
  • DOGZ N/A
  • Revenue
  • ZLAB $418,326,000.00
  • DOGZ $20,258,926.00
  • Revenue This Year
  • ZLAB $44.07
  • DOGZ N/A
  • Revenue Next Year
  • ZLAB $49.13
  • DOGZ N/A
  • P/E Ratio
  • ZLAB N/A
  • DOGZ N/A
  • Revenue Growth
  • ZLAB 43.72
  • DOGZ 46.16
  • 52 Week Low
  • ZLAB $16.01
  • DOGZ $8.64
  • 52 Week High
  • ZLAB $44.34
  • DOGZ $58.50
  • Technical
  • Relative Strength Index (RSI)
  • ZLAB 40.19
  • DOGZ 22.73
  • Support Level
  • ZLAB $34.26
  • DOGZ $9.04
  • Resistance Level
  • ZLAB $35.72
  • DOGZ $10.58
  • Average True Range (ATR)
  • ZLAB 1.12
  • DOGZ 2.95
  • MACD
  • ZLAB -0.54
  • DOGZ -1.67
  • Stochastic Oscillator
  • ZLAB 3.83
  • DOGZ 3.15

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

About DOGZ Dogness (International) Corporation

Dogness (International) Corp designs, manufactures pet products, including leashes and smart products, and lanyards. The company designs, processes, and manufactures fashionable and high-quality leashes, collars, and harnesses to complement cats' and dogs' appearances, as well as intelligent pet products. The company also provides dyeing services to external customers, as well as pet grooming services. The dyeing service is to utilize the existing production capacity and the pet grooming service is immaterial. Geographically, it generates maximum revenue from Mainland China and also has a presence in the United States, Europe, Australia, Canada, Central, and South America, Japan, and other Asian countries and regions.

Share on Social Networks: